Nagata S - Search Results

1

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P. Kägi D, et al. Among authors: nagata s. Science. 1994 Jul 22;265(5171):528-30. doi: 10.1126/science.7518614. Science. 1994. PMID: 7518614

2

The Fas death factor.

Nagata S, Golstein P. Nagata S, et al. Science. 1995 Mar 10;267(5203):1449-56. doi: 10.1126/science.7533326. Science. 1995. PMID: 7533326 Review.

3

TCR/CD3 coupling to Fas-based cytotoxicity.

Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P. Vignaux F, et al. Among authors: nagata s. J Exp Med. 1995 Feb 1;181(2):781-6. doi: 10.1084/jem.181.2.781. J Exp Med. 1995. PMID: 7530763 Free PMC article.

4

Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.

Ehl S, Hoffmann-Rohrer U, Nagata S, Hengartner H, Zinkernagel R. Ehl S, et al. Among authors: nagata s. J Immunol. 1996 Apr 1;156(7):2357-60. J Immunol. 1996. PMID: 8786290

5

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Suda T, Takahashi T, Golstein P, Nagata S. Suda T, et al. Among authors: nagata s. Cell. 1993 Dec 17;75(6):1169-78. doi: 10.1016/0092-8674(93)90326-l. Cell. 1993. PMID: 7505205

6

Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.

Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC. Estaquier J, et al. Among authors: nagata s. Blood. 1996 Jun 15;87(12):4959-66. Blood. 1996. PMID: 8652808 Free article.

7

Levels of soluble Fas ligand in myocarditis.

Toyozaki T, Hiroe M, Tanaka M, Nagata S, Ohwada H, Marumo F. Toyozaki T, et al. Among authors: nagata s. Am J Cardiol. 1998 Jul 15;82(2):246-8. doi: 10.1016/s0002-9149(98)00300-2. Am J Cardiol. 1998. PMID: 9678301

8

Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.

Oshimi Y, Oda S, Honda Y, Nagata S, Miyazaki S. Oshimi Y, et al. Among authors: nagata s. J Immunol. 1996 Oct 1;157(7):2909-15. J Immunol. 1996. PMID: 8816396

9

Fas-mediated apoptosis.

Nagata S. Nagata S. Adv Exp Med Biol. 1996;406:119-24. doi: 10.1007/978-1-4899-0274-0_12. Adv Exp Med Biol. 1996. PMID: 8910677 Review.

10

Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.

Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H. Hashimoto W, et al. Among authors: nagata s. J Immunol. 1999 Jul 15;163(2):583-9. J Immunol. 1999. PMID: 10395644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,147 results

Search Page

Filters